Table of Content

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising geriatric population
4.2.2 Rising cardiovascular diseases
4.2.3 Research and development
4.3 Restraints
4.3.1 High cost
4.3.2 Regulatory affairs
4.4 Opportunity
4.4.1 Entering developing markets
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Price Analysis
5.3 Investment Opportunity Analysis
5.4 Value Chain Analysis
5.4.1 Supporting Activity
5.4.2 Inbound Logistics
5.4.3 Operations
5.4.4 Marketing and Sales
5.4.5 Outbound Logistics
5.4.6 Customer Services
6 Global Cardiopulmonary Exercise Testing Market, by Product
6.1 Introduction
6.2 Cardiopulmonary Exercise Testing (CPET) Systems
6.3 Single-Photon Emission Computed Tomography (SPECT)
6.4 Echocardiogram
6.5 Pulse Oximeters
6.6 Stress Blood Pressure Monitors
7 Global Cardiopulmonary Exercise Testing Market, by End-User
7.1 Introduction
7.2 Hospitals and Clinics
7.3 Diagnostic Centers
7.4 Ambulatory Centers
7.5 Others
8 Global Cardiopulmonary Exercise Testing Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 U.K.
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East and Africa
8.5.1 Middle East
8.5.2 Africa
9 Company Landscape
9.1 Company Share Analysis
10 Company Profiles
10.1 Cardinal Health
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offering
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategy
10.2 COSMED srl
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offering
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategy
10.3 GE Healthcare
10.3.1 Company Overview
10.3.2 Financial Overview (Healthcare Segment)
10.3.3 Products Offering
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategy
10.4 Halma plc.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offering
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategy
10.5 Hill-Rom Holdings, Inc.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offering
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategy
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offering
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategy
10.7 MGC Diagnostics Corporation
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products Offering
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategy
10.8 NIHON KOHDEN CORPORATION
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products Offering
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategy
10.9 Schiller AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offering
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategy
10.1 Masimo Corporation
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products Offering
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategy
10.11 Vyaire Medical, Inc.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products Offering
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.11.6 Key Strategy
11 Appendix
11.1 Discussion Blue Print
11.2 References



List of Figures



FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES
FIGURE 2 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET
FIGURE 3 PORTER’S FIVE FORCES MODEL
FIGURE 4 VALUE CHAIN: CARDIOPULMONARY EXERCISE TESTING MARKET
FIGURE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2017 & 2023 (USD MILLION)
FIGURE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2017 & 2023 (USD MILLION)
FIGURE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 & 2023 (USD MILLION)
FIGURE 8 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)
FIGURE 9 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017 (%)
FIGURE 10 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)
FIGURE 11 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017 (%)
FIGURE 12 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017(%)
FIGURE 13 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)
FIGURE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET COMPANY SHARE ANALYSIS, 2017 (%)

 

List of Tables



TABLE 1 PRIMARY INTERVIEWS
TABLE 2 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 3 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR CARDIOPULMONARY EXERCISE TESTING (CPET) SYSTEMS, BY REGION, 2015–2023 (USD MILLION)
TABLE 4 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2015–2023 (USD MILLION)
TABLE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR ECHOCARDIOGRAM, BY REGION, 2015–2023 (USD MILLION)
TABLE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR PULSE OXIMETERS, BY REGION, 2015–2023 (USD MILLION)
TABLE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR STRESS BLOOD PRESSURE MONITORS, BY REGION, 2015–2023 (USD MILLION)
TABLE 8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2015–2023 (USD MILLION)
TABLE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015–2023 (USD MILLION)
TABLE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR AMBULATORY CENTERS, BY REGION, 2015–2023 (USD MILLION)
TABLE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 13 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 14 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 15 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 16 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 17 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 18 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 19 U.S. CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 20 U.S. CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 21 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 22 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 23 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 24 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 25 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 26 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 27 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 28 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 29 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 30 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 31 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 32 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 33 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 34 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 35 U.K. CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 36 U.K. CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 37 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 38 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 39 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 40 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 41 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 42 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 43 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 44 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 45 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 46 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 47 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 48 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 49 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 50 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 51 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 52 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 53 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 54 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 55 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 56 REPUBLIC OF KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 57 REPUBLIC OF KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 58 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 59 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 63 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 64 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 65 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)
TABLE 66 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)